Why CVS Health Corp. (CVS) stock moved
CVS Health Corp. (CVS) shares fell 0.2% to $92.36 as of October 18, 2026, a slight decline from the prior close of $92.58. BestStocks flagged the session as a major change for CVS. The move is tied to company news. Below, we break down what changed for CVS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
CVS Health partners with The Midlife Collective to conduct midlife health research and produce a documentary. Positions CVS to capture emerging midlife wellness market and build brand loyalty among high-spending demographic.
What it means for CVS Health Corp. investors
For CVS Health Corp. investors, the recent signals add up to a bearish shift. On the constructive side: CVS Health Corp. (CVS) moved +5.76% from $93.72 to $99.12 on 2026-08-05. Weighing against that: Negative session, down 0.2%; CVS Health fell 2.17% to $93.59 as investors absorbed disappointing preliminary 2027 profit guidance released last week, alongside ongoing regulatory scrutiny over its vertically integrated business model and persistent pressures in its pharmacy benefit manager segment. Because peers moved similarly, the shift looks more macro- or sector-driven than a change in CVS's fundamentals. Wall Street's consensus price target sits at $111.25, implying +20.5% upside from $92.36. BestStocks rates the overall signal quality weak (33/100). With earnings roughly 17 days out, the next report is the most likely near-term test of the move.
CVS price reaction
CVS last traded at $92.36, down $0.22 (-0.24%) from the previous close of $92.58. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Its healthcare peer group moved a median +0.5% over the same stretch, leaving CVS behind the group by 0.7 points. Over the past month the stock has ranged between $85.05 and $92.58, and it currently sits about 97% of the way up that band.
Bullish and bearish analyst opinions on CVS Health Corp. (CVS)
The consensus analyst price target on CVS Health Corp. (CVS) is $111.25, 20.5% above the recent $92.36. Over the past 90 days analysts logged 0 upgrades, 8 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CVS line up.
The bullish case
- Wall Street's consensus price target of $111.25 implies +20.5% upside from $92.36.
- The Street's most bullish target is $123.00 (+33.2%).
- CVS Health Corp. (CVS) moved +5.76% from $93.72 to $99.12 on 2026-08-05.
The bearish case
- The most bearish analyst target is $92.00 (-0.4%).
- Negative session, down 0.2%.
- CVS Health fell 2.17% to $93.59 as investors absorbed disappointing preliminary 2027 profit guidance released last week, alongside ongoing regulatory scrutiny over its vertically integrated business model and persistent pressures in its pharmacy benefit manager segment.
- CVS Health Corp. moved -5.27% intraday from $104.42 to $98.92.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 18, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CVS
Frequently asked questions about CVS
Why did CVS Health Corp. (CVS) stock move?
CVS fell 0.2% to $92.36. The move coincided with the context summarized above, which BestStocks classifies as a sector-wide move, though no single company-specific catalyst was independently confirmed.
How much did CVS stock fall?
CVS lost 0.24% ($0.22) versus the prior close of $92.58, last trading at $92.36 on 0.9× average volume.
When is CVS Health Corp.'s next earnings date?
CVS's next earnings report is estimated for 2026-11-04 — about 17 days away.
What is the analyst price target for CVS?
The consensus analyst price target for CVS is $111.25, about 20.5% above the current $92.36. Over the past 90 days, analysts recorded 0 upgrades, 8 maintains, and 0 downgrades.
Is the CVS move company-specific or sector-wide?
BestStocks classifies it as a sector-wide move: the peer group moved a median +0.5% against CVS's -0.2%. CVS ranks top 6 of 7 peers.
How BestStocks tracks CVS
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for CVS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 18, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.